MOESM2 of The plasma peptides of ovarian cancer | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

MOESM2 of Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population

Atif Hashmi (5354507)
Samreen Naz (5354510)
Shumaila Hashmi (5354501)
Zubaida Hussain (5354504)
Muhammad Irfan (255476)
Syed Bakar (5354495)
Naveen Faridi (5354498)
Amir Khan (216804)
Muhammad Edhi (3472298)

June 2018

Additional file 2: Figure S2. Kalpien-Meier curve (disease free survival) for CK 8/18 expression in ...

MOESM2 of Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles

Stephanie Antoun (4808544)
David Atallah (3751273)
Roula Tahtouh (714734)
Nada Alaaeddine (714736)
Malak Moubarak (4761861)
Abir Khaddage (4808541)
Eliane Ayoub (4808547)
George Chahine (370635)
George Hilal (714741)

January 2018

Additional file 2: Table S2. Clinical and histopathological characteristics of tumors

MOESM4 of An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

Qing Li (84975)
Punit Shah (1326501)
Yuan Tian (225002)
Yingwei Hu (1837675)
Richard Roden (3191487)
Hui Zhang (7197)
Daniel Chan (3873598)

May 2017

Additional file 4: Table S4. Glycosite-containing peptides identified from glycoproteomic analysis f...

MOESM2 of A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

Stefan Enroth (189126)
Malin Berggrund (6035387)
Maria Lycke (6035390)
Martin Lundberg (584387)
Erika Assarsson (58597)
Matts Olovsson (3225774)
Karin StĂĽlberg (6035393)
Karin Sundfeldt (754806)
Ulf Gyllensten (13773)

December 2018

Additional file 2: TableÂ 2. CA125 values in the clinical analyses and the PEA NPX values for some o...

MOESM1 of A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

Stefan Enroth (189126)
Malin Berggrund (6035387)
Maria Lycke (6035390)
Martin Lundberg (584387)
Erika Assarsson (58597)
Matts Olovsson (3225774)
Karin StĂĽlberg (6035393)
Karin Sundfeldt (754806)
Ulf Gyllensten (13773)

December 2018

Additional file 1: TableÂ 1. P-values of individual proteins in the discovery step

MOESM1 of A multiplex platform for the identification of ovarian cancer biomarkers

Kristin Boylan (4504465)
Kate Geschwind (3554222)
Joseph Koopmeiners (3554213)
Melissa Geller (4504468)
Timothy Starr (3542831)
Amy Skubitz (3554216)

October 2017

Additional file 1. List of all 92 proteins with their significance in trends among patient subgroups...

MOESM2 of An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

Qing Li (84975)
Punit Shah (1326501)
Yuan Tian (225002)
Yingwei Hu (1837675)
Richard Roden (3191487)
Hui Zhang (7197)
Daniel Chan (3873598)

May 2017

Additional file 2: Table S2. Glycosite-containing peptides identified from glycoproteomic analysis f...

MOESM2 of Differential analysis of quantitative proteome and acetyl-proteome profiling between premenopausal and postmenopausal ovarian tissues

Jinling Yi (5983832)
Huatianshu Hu (5983835)
Peipei Shi (3608189)
Song Shi (195110)
Junda Zhao (5983838)
Linna Xu (4328155)
Weining Yang (139409)
Bin Li (39349)
Jin Zhu (164147)
Shien Zou (398500)

November 2018

Additional file 2: Table S2. Differential protein expression in postmenopause and premenopause sampl...

MOESM2 of Tumor size, stage and grade alterations of urinary peptidome in RCC

Clizia Chinello (627385)
Marta Cazzaniga (627386)
Gabriele Sio (3550580)
Andrew Smith (11197)
Angelica Grasso (627390)
Bernardo Rocco (759657)
Stefano Signorini (67210)
Marco Grasso (338528)
Silvano Bosari (65835)
Italo Zoppis (568980)
Giancarlo Mauri (19520)
Fulvio Magni (627391)

October 2015

Additional file 2: Table S2. A) Peptides with a statistically significant (p < 0.05) urinary abund...

Additional file 2: of Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment

Chrysi Xintaropoulou (5337881)
Carol Ward (693454)
Alan Wise (5337884)
Suzanna Queckborner (5337872)
Arran Turnbull (5337878)
Caroline Michie (5337875)
Alistair Williams (677760)
Tzyvia Rye (4733277)
Charlie Gourley (438864)
Simon Langdon (2163259)

June 2018

TMA dataset. Mean AQUA expression values for GLUT1, LDHA, HKII and PKM2 in 380 ovarian cancer sample...

MOESM1 of Tumor size, stage and grade alterations of urinary peptidome in RCC

Clizia Chinello (627385)
Marta Cazzaniga (627386)
Gabriele Sio (3550580)
Andrew Smith (11197)
Angelica Grasso (627390)
Bernardo Rocco (759657)
Stefano Signorini (67210)
Marco Grasso (338528)
Silvano Bosari (65835)
Italo Zoppis (568980)
Giancarlo Mauri (19520)
Fulvio Magni (627391)

October 2015

Additional file 1: Table S1. Peptides with a statistically significant (p < 0.05) urinary abundanc...

MOESM2 of Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population

Atif Hashmi (5354507)
Samreen Naz (5354510)
Shumaila Hashmi (5354501)
Zubaida Hussain (5354504)
Muhammad Irfan (255476)
Syed Bakar (5354495)
Naveen Faridi (5354498)
Amir Khan (216804)
Muhammad Edhi (3472298)

June 2018

Additional file 2: Figure S2. Kalpien-Meier curve (disease free survival) for CK 8/18 expression in ...

MOESM2 of Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles

Stephanie Antoun (4808544)
David Atallah (3751273)
Roula Tahtouh (714734)
Nada Alaaeddine (714736)
Malak Moubarak (4761861)
Abir Khaddage (4808541)
Eliane Ayoub (4808547)
George Chahine (370635)
George Hilal (714741)

January 2018

Additional file 2: Table S2. Clinical and histopathological characteristics of tumors

MOESM4 of An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

Qing Li (84975)
Punit Shah (1326501)
Yuan Tian (225002)
Yingwei Hu (1837675)
Richard Roden (3191487)
Hui Zhang (7197)
Daniel Chan (3873598)

May 2017

Additional file 4: Table S4. Glycosite-containing peptides identified from glycoproteomic analysis f...

MOESM2 of A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

Stefan Enroth (189126)
Malin Berggrund (6035387)
Maria Lycke (6035390)
Martin Lundberg (584387)
Erika Assarsson (58597)
Matts Olovsson (3225774)
Karin StĂĽlberg (6035393)
Karin Sundfeldt (754806)
Ulf Gyllensten (13773)

December 2018

Additional file 2: TableÂ 2. CA125 values in the clinical analyses and the PEA NPX values for some o...

MOESM1 of A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

Stefan Enroth (189126)
Malin Berggrund (6035387)
Maria Lycke (6035390)
Martin Lundberg (584387)
Erika Assarsson (58597)
Matts Olovsson (3225774)
Karin StĂĽlberg (6035393)
Karin Sundfeldt (754806)
Ulf Gyllensten (13773)

December 2018

Additional file 1: TableÂ 1. P-values of individual proteins in the discovery step

MOESM2 of An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

Qing Li (84975)
Punit Shah (1326501)
Yuan Tian (225002)
Yingwei Hu (1837675)
Richard Roden (3191487)
Hui Zhang (7197)
Daniel Chan (3873598)

May 2017

Additional file 2: Table S2. Glycosite-containing peptides identified from glycoproteomic analysis f...

MOESM2 of Differential analysis of quantitative proteome and acetyl-proteome profiling between premenopausal and postmenopausal ovarian tissues

Jinling Yi (5983832)
Huatianshu Hu (5983835)
Peipei Shi (3608189)
Song Shi (195110)
Junda Zhao (5983838)
Linna Xu (4328155)
Weining Yang (139409)
Bin Li (39349)
Jin Zhu (164147)
Shien Zou (398500)

November 2018

Additional file 2: Table S2. Differential protein expression in postmenopause and premenopause sampl...

MOESM2 of Tumor size, stage and grade alterations of urinary peptidome in RCC

Clizia Chinello (627385)
Marta Cazzaniga (627386)
Gabriele Sio (3550580)
Andrew Smith (11197)
Angelica Grasso (627390)
Bernardo Rocco (759657)
Stefano Signorini (67210)
Marco Grasso (338528)
Silvano Bosari (65835)
Italo Zoppis (568980)
Giancarlo Mauri (19520)
Fulvio Magni (627391)

October 2015

Additional file 2: Table S2. A) Peptides with a statistically significant (p < 0.05) urinary abund...

Additional file 2: of Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment

Chrysi Xintaropoulou (5337881)
Carol Ward (693454)
Alan Wise (5337884)
Suzanna Queckborner (5337872)
Arran Turnbull (5337878)
Caroline Michie (5337875)
Alistair Williams (677760)
Tzyvia Rye (4733277)
Charlie Gourley (438864)
Simon Langdon (2163259)

June 2018

TMA dataset. Mean AQUA expression values for GLUT1, LDHA, HKII and PKM2 in 380 ovarian cancer sample...

MOESM1 of Tumor size, stage and grade alterations of urinary peptidome in RCC

Clizia Chinello (627385)
Marta Cazzaniga (627386)
Gabriele Sio (3550580)
Andrew Smith (11197)
Angelica Grasso (627390)
Bernardo Rocco (759657)
Stefano Signorini (67210)
Marco Grasso (338528)
Silvano Bosari (65835)
Italo Zoppis (568980)
Giancarlo Mauri (19520)
Fulvio Magni (627391)

October 2015

Additional file 1: Table S1. Peptides with a statistically significant (p < 0.05) urinary abundanc...

MOESM2 of Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population

Atif Hashmi (5354507)
Samreen Naz (5354510)
Shumaila Hashmi (5354501)
Zubaida Hussain (5354504)
Muhammad Irfan (255476)
Syed Bakar (5354495)
Naveen Faridi (5354498)
Amir Khan (216804)
Muhammad Edhi (3472298)

June 2018

Additional file 2: Figure S2. Kalpien-Meier curve (disease free survival) for CK 8/18 expression in ...

MOESM2 of Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles

Stephanie Antoun (4808544)
David Atallah (3751273)
Roula Tahtouh (714734)
Nada Alaaeddine (714736)
Malak Moubarak (4761861)
Abir Khaddage (4808541)
Eliane Ayoub (4808547)
George Chahine (370635)
George Hilal (714741)

January 2018

Additional file 2: Table S2. Clinical and histopathological characteristics of tumors

MOESM4 of An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

Qing Li (84975)
Punit Shah (1326501)
Yuan Tian (225002)
Yingwei Hu (1837675)
Richard Roden (3191487)
Hui Zhang (7197)
Daniel Chan (3873598)

May 2017

Additional file 4: Table S4. Glycosite-containing peptides identified from glycoproteomic analysis f...